New Zealand markets closed

ADMA Biologics, Inc. (ADMA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
11.18+0.23 (+2.10%)
At close: 04:00PM EDT
11.08 -0.10 (-0.89%)
After hours: 07:56PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 2.59B
Enterprise value 2.69B
Trailing P/E N/A
Forward P/E 30.21
PEG ratio (5-yr expected) N/A
Price/sales (ttm)8.98
Price/book (mrq)16.85
Enterprise value/revenue 9.48
Enterprise value/EBITDA 95.75

Trading information

Stock price history

Beta (5Y monthly) 0.48
52-week change 3204.63%
S&P500 52-week change 322.55%
52-week high 311.27
52-week low 33.06
50-day moving average 38.95
200-day moving average 35.71

Share statistics

Avg vol (3-month) 32.91M
Avg vol (10-day) 33.78M
Shares outstanding 5231.81M
Implied shares outstanding 6231.81M
Float 8227.8M
% held by insiders 12.59%
% held by institutions 177.98%
Shares short (14 Jun 2024) 49.44M
Short ratio (14 Jun 2024) 43.21
Short % of float (14 Jun 2024) 44.20%
Short % of shares outstanding (14 Jun 2024) 44.07%
Shares short (prior month 15 May 2024) 48.44M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -1.29%
Operating margin (ttm)26.65%

Management effectiveness

Return on assets (ttm)8.51%
Return on equity (ttm)-2.43%

Income statement

Revenue (ttm)283.18M
Revenue per share (ttm)1.25
Quarterly revenue growth (yoy)43.90%
Gross profit (ttm)N/A
EBITDA 55.47M
Net income avi to common (ttm)-3.64M
Diluted EPS (ttm)-0.02
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)45.33M
Total cash per share (mrq)0.2
Total debt (mrq)141.43M
Total debt/equity (mrq)92.01%
Current ratio (mrq)5.21
Book value per share (mrq)0.66

Cash flow statement

Operating cash flow (ttm)21.3M
Levered free cash flow (ttm)7.84M